NEW YORK (GenomeWeb) – Molecular diagnostics firm Paradigm announced today that it has signed a deal under which its PCDx next-generation sequencing-based cancer test will be covered by health insurer Three Rivers Provider Network.

According to Paradigm, Three Rivers has more than 15 million US members.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.